Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,357 | 67 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $421.14 | 23 | $0 (2024) |
| Lilly USA, LLC | $192.39 | 10 | $0 (2024) |
| iRhythm Technologies, Inc. | $179.83 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $151.27 | 8 | $0 (2024) |
| Medtronic Vascular, Inc. | $75.25 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $68.07 | 4 | $0 (2024) |
| PFIZER INC. | $63.36 | 4 | $0 (2024) |
| Exact Sciences Corporation | $59.10 | 4 | $0 (2024) |
| Currax Pharmaceuticals LLC | $31.63 | 2 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $31.59 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $759.91 | 35 | Novo Nordisk Inc ($198.23) |
| 2023 | $428.61 | 25 | Novo Nordisk Inc ($158.76) |
| 2017 | $168.71 | 7 | Medtronic Vascular, Inc. ($75.25) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Hematology | ||||||
| 12/05/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Obesity | ||||||
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 05/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: RESPIRATORY | ||||||
| 04/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 972 | 1,248 | $211,932 | $69,790 |
| 2022 | 12 | 967 | 1,313 | $128,691 | $82,897 |
| 2021 | 12 | 844 | 1,179 | $114,182 | $72,482 |
| 2020 | 14 | 918 | 1,403 | $134,366 | $72,714 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 287 | $76,216 | $23,347 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 246 | $44,040 | $13,571 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 106 | 106 | $29,892 | $12,638 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $22,904 | $6,077 | 26.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $6,867 | $4,460 | 64.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $7,825 | $2,256 | 28.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 66 | $2,046 | $1,881 | 91.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 56 | 56 | $2,632 | $936.32 | 35.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 23 | 23 | $4,082 | $932.65 | 22.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 48 | 48 | $2,256 | $802.56 | 35.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 71 | $2,698 | $675.92 | 25.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 15 | $2,580 | $534.66 | 20.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 32 | $1,408 | $519.04 | 36.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 50 | $3,000 | $516.00 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 16 | $1,712 | $453.75 | 26.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $1,220 | $178.84 | 14.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 13 | 17 | $374.00 | $6.75 | 1.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 45 | $180.00 | $4.42 | 2.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 336 | $47,040 | $27,840 | 59.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 173 | 173 | $25,950 | $21,693 | 83.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 226 | $22,600 | $13,226 | 58.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 156 | 160 | $19,840 | $12,712 | 64.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 36 | $4,320 | $1,946 | 45.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 57 | 58 | $1,740 | $1,588 | 91.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 56 | 57 | $1,482 | $1,144 | 77.2% |
About Dr. Gilbert Douglas, D.O
Dr. Gilbert Douglas, D.O is a Internal Medicine healthcare provider based in Gardendale, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1881865103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Douglas, D.O has received a total of $1,357 in payments from pharmaceutical and medical device companies, with $759.91 received in 2024. These payments were reported across 67 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,357).
As a Medicare-enrolled provider, Douglas has provided services to 3,701 Medicare beneficiaries, totaling 5,143 services with total Medicare billing of $297,884. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Gardendale, AL
- Active Since 03/14/2008
- Last Updated 02/02/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881865103
Products in Payments
- MOUNJARO (Drug) $172.07
- Zio monitor (Device) $164.95
- Rybelsus (Drug) $148.89
- Ozempic (Drug) $140.88
- TRELEGY ELLIPTA (Drug) $92.14
- VenaSeal (Device) $75.25
- Victoza (Drug) $64.15
- AREXVY (Drug) $59.13
- Cologuard Collection Kit (Device) $59.10
- Wegovy (Drug) $45.84
- AIRSUPRA (Drug) $36.74
- JARDIANCE (Drug) $33.42
- CONTRAVE (Drug) $31.63
- ACCRUFER (Drug) $31.59
- PAXLOVID (Drug) $25.85
- ZTLido (Drug) $21.45
- NURTEC ODT (Drug) $21.30
- KRYSTEXXA (Biological) $17.43
- Xhance (Drug) $17.39
- LYRICA (Drug) $16.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gardendale
Steven King, Md, MD
Internal Medicine — Payments: $11,120
Dr. Benjamin Broome, M.d, M.D
Internal Medicine — Payments: $3,298
John Nichols, M.d, M.D
Internal Medicine — Payments: $1,643
Arthur Patton, M.d, M.D
Internal Medicine — Payments: $1,399
John Cantrell, D.o, D.O
Internal Medicine — Payments: $1,275
Melissa Toner, M.d, M.D
Internal Medicine — Payments: $1,090